Last quarter (Q3 2023), Hims & Hers Health's total revenue was $226.70M, an increase of 56.52% from the same quarter last year. In Q3, Hims & Hers Health's net income was $80.19M. See Hims & Hers Health’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 792.58M	$ 526.92M	$ 271.88M	$ 148.76M	$ 0.00
Cost of Revenue	$ 79.62M	$ 118.19M	$ -67.38M	$ 39.31M	-
Gross Profit	$ 643.23M	$ 408.72M	$ 204.49M	$ 109.45M	-
Operating Expense	$ 396.00M	$ 477.42M	$ -319.54M	$ 124.59M	$ 1.31M
Operating Income	$ 41.47M	$ -68.70M	$ -115.04M	$ -15.14M	$ -1.31M
Net Non Operating Interest Income Expense	$ -39.95M	-	-	$ -10.00K	-
Other Income Expense	$ -6.80M	$ -2.92M	$ -445.00K	$ -2.83M	$ 7.36M
Pretax Income	$ -34.80M	$ -65.71M	$ -110.80M	$ -17.99M	$ 6.05M
Tax Provision	$ 903.00K	$ -31.00K	$ -3.14M	$ 127.00K	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ 52.06M	$ 147.53M	$ -107.66M	$ -18.11M	$ 6.05M
Basic EPS	$ -0.17	$ -0.32	$ -0.58	$ -0.51	$ 0.08
Diluted EPS	$ -0.17	$ -0.32	$ -0.58	$ -0.51	$ 0.08
Basic Average Shares	$ 830.21M	$ 204.52M	$ 186.78M	$ 35.35M	$ 25.16M
Diluted Average Shares	$ 830.21M	$ 204.52M	$ 186.78M	$ 189.86M	$ 25.16M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 475.63M	$ 595.61M	$ -386.92M	$ 163.90M	$ 1.31M
Net Income From Continuing And Discontinued Operation	$ -35.70M	$ -65.70M	$ -107.66M	$ -18.11M	$ 6.05M
Normalized Income	$ -5.46M	$ -65.04M	-	$ -15.85M	$ 676.62K
Interest Expense	-	-	-	$ 10.00K	-
EBIT	$ 5.16M	$ -65.71M	$ -110.80M	$ -17.98M	$ -1.31M
EBITDA	$ 9.15M	$ -58.09M	$ -104.41M	$ -16.92M	$ -1.31M

Currency in USD

Hims & Hers Health Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing